Advertisement

Ads Placeholder
Loading...

GSK plc

GLAXF•PNK
Healthcare
Drug Manufacturers - General
$26.55
$-0.70(-2.57%)
U.S. Market is Open • 15:37

GSK plc (GLAXF) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap107B
P/E Ratio14.26
EPS (TTM)$1.84
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$24.83
3 Months$35.17
1 Year Target$25.06

GLAXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GLAXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $25.06.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.26 and a market capitalization of 107B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.83%
5-Day Change
-1.83%
1-Month Change
-3.25%
3-Month Change
13.35%
6-Month Change
23.39%
Year-to-Date (YTD) Change
13.35%
1-Year Change
46.10%
3-Year Change
52.60%
5-Year Change
19.53%
All-Time (Max) Change
5.94%

Contact Information

https://www.gsk.com
44 20 8047 5000
980 Great West Road, Brentford, NaN, TW8 9GS

Company Facts

686,290 Employees
IPO DateJan 5, 2010
CountryGB
Actively Trading

Frequently Asked Questions